These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Preocclusive perfusion area as a determinant of infarct size in a canine model. Sakai K; Tomoike H; Ootsubo H; Kikuchi Y; Nakamura M Cardiovasc Res; 1982 Jul; 16(7):408-16. PubMed ID: 7127355 [TBL] [Abstract][Full Text] [Related]
26. Localization of radiolabeled cardiac myosin-specific antibody in myocardial infarcts. Comparison with technetium-99m stannous pyrophosphate. Beller GA; Khaw BA; Haber E; Smith TW Circulation; 1977 Jan; 55(1):74-8. PubMed ID: 830221 [TBL] [Abstract][Full Text] [Related]
27. Effect of methylprednisolone upon technetium-99m pyrophosphate assessment myocardial necrosis in the canine countershock model. Schneider RM; Hayslett JP; Downing SE; Berger HJ; Donabedian RK; Zaret BL Circulation; 1977 Dec; 56(6):1029-34. PubMed ID: 923041 [TBL] [Abstract][Full Text] [Related]
28. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability. Sansoy V; Glover DK; Watson DD; Ruiz M; Smith WH; Simanis JP; Beller GA Circulation; 1995 Aug; 92(4):994-1004. PubMed ID: 7641384 [TBL] [Abstract][Full Text] [Related]
30. Limitation of infarct size with preconditioning and calcium antagonist (diltiazem): difference in 99mTc-PYP uptake in the myocardium. Okuda K; Nohara R; Ogino M; Tamaki N; Konishi J; Fujita M; Sasayama S Ann Nucl Med; 1996 May; 10(2):201-9. PubMed ID: 8800449 [TBL] [Abstract][Full Text] [Related]
31. Differentiation between reperfusion and occlusion myocardial necrosis with technetium-99m pyrophospate scans. Long R; Symes J; Allard J; Burdon T; Lisbona R; Huttner I; Sniderman A Am J Cardiol; 1980 Sep; 46(3):413-8. PubMed ID: 7415986 [TBL] [Abstract][Full Text] [Related]
33. Technetium pyrophosphate scanning in the detection of acute myocardial infarction: clinical experience. Ko P; Kostuk WJ; Deatrich D Can Med Assoc J; 1977 Feb; 116(3):260-3. PubMed ID: 189887 [TBL] [Abstract][Full Text] [Related]
34. 99mTc-labelled pyrophosphate myocardial scanning in experiment and in clinical practice. Vizda J; Duska F; Kubícek J; Kafka P; Novák J; Mazurová Y Cor Vasa; 1981; 23(6):457-66. PubMed ID: 6277567 [TBL] [Abstract][Full Text] [Related]
36. [Infarct size determined by emission computed tomography using 99mTc-PYP: effect of coronary thrombolysis]. Fujisue R; Ohyanagi M; Naruse H; Todo Y; Yukimasa T; Ikeoka K; Tsuda Y; Yamamoto T; Iwasaki T; Fukuchi M J Cardiol; 1987 Sep; 17(3):437-44. PubMed ID: 2840489 [TBL] [Abstract][Full Text] [Related]
37. [Marked 99mTc-PYP myocardial accumulation immediately after reperfusion in a patient with acute myocardial infarction]. Adachi Y; Ito K; Nishikawa S; Yuba T; Tsubakimoto Y; Takata H; Kato S; Azuma A; Sugihara H; Nakagawa M Kaku Igaku; 2003 Feb; 40(1):11-6. PubMed ID: 12701202 [TBL] [Abstract][Full Text] [Related]
38. Does the extent of the zone at risk after coronary artery occlusion influence the percentage of the zone that evolves to infarction? Endo T; Kiuchi K; Sato N; Hayakawa H; Okumura H Cardiology; 1990; 77(2):112-20. PubMed ID: 2397488 [TBL] [Abstract][Full Text] [Related]
39. Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs. Endo T; Nejima J; Fujita S; Kiuchi K; Iida N; Kikuchi K; Hayakawa H; Okumura H Circulation; 1986 Aug; 74(2):420-30. PubMed ID: 3731430 [TBL] [Abstract][Full Text] [Related]
40. Technetium-99m(Sn2+)pyrophosphate in ischemic and infarcted dog myocardium in early stages of acute coronary occlusion: histochemical and tissue-counting comparisons. Bianco JA; Kemper AJ; Taylor A; Lazewatsky J; Tow DE; Khuri SF J Nucl Med; 1983 Jun; 24(6):485-91. PubMed ID: 6854398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]